MELAZTE 5 MG CAP DURA CT FR VD AMB X 5
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1029805860014 -
GGREM
506724060100704 -
Código de barras
7896676440997
O que a fonte publica
- Detentor do registro
- CRISTÁLIA PRODUTOS QUÍMICOS FARMACÊUTICOS LTDA.
- Princípios ativos
- TEMOZOLOMIDA
- Embalagem
- 5 MG CAP DURA CT FR VD AMB X 5
- Regime de dispensação
- Tarja Vermelha
- Tipo de produto
- Similar
- Classe terapêutica
- L1A - AGENTES ANTINEOPLÁSICOS ALQUILANTES
- Prescrição
- Sob prescrição ou restrito
Nomes pelos quais este registro é encontrado
Dados completos da fonte
{
"name": "MELAZTE 5 MG CAP DURA CT FR VD AMB X 5",
"holder": "CRISTÁLIA PRODUTOS QUÍMICOS FARMACÊUTICOS LTDA.",
"stripe": "Tarja Vermelha",
"barcodes": [
"7896676440997"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "506724060100704",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": true,
"holderTaxId": "44.734.671/0001-51",
"priceRegime": "Regulado",
"productName": "MELAZTE",
"productType": "Similar",
"hospitalOnly": false,
"presentation": "5 MG CAP DURA CT FR VD AMB X 5",
"sourceStatus": null,
"supplyRegime": "Tarja Vermelha",
"factoryPrices": {
"icms-0": "182.22",
"icms-12": "207.07",
"icms-17": "219.54",
"icms-18": "222.22",
"icms-19": "224.96",
"icms-20": "227.78",
"icms-21": "230.66",
"icms-22": "233.62",
"icms-23": "236.65",
"icms-17.5": "220.87",
"icms-19.5": "226.36",
"icms-20.5": "229.21",
"icms-22.5": "235.12",
"icms-12-alc": "204.58",
"icms-17-alc": "216.91",
"icms-18-alc": "219.55",
"icms-19-alc": "222.26",
"icms-20-alc": "225.04",
"icms-21-alc": "227.89",
"icms-22-alc": "230.81",
"icms-23-alc": "233.81",
"withoutTaxes": "180.03",
"icms-17.5-alc": "218.22",
"icms-19.5-alc": "223.64",
"icms-20.5-alc": "226.46",
"icms-22.5-alc": "232.30"
},
"pisCofinsList": "Positiva",
"substanceText": "TEMOZOLOMIDA",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "251.17",
"icms-12": "285.42",
"icms-17": "302.61",
"icms-18": "306.31",
"icms-19": "310.08",
"icms-20": "313.97",
"icms-21": "317.94",
"icms-22": "322.02",
"icms-23": "326.20",
"icms-17.5": "304.45",
"icms-19.5": "312.01",
"icms-20.5": "315.94",
"icms-22.5": "324.09",
"icms-12-alc": "282.82",
"icms-17-alc": "299.87",
"icms-18-alc": "303.51",
"icms-19-alc": "307.26",
"icms-20-alc": "311.10",
"icms-21-alc": "315.04",
"icms-22-alc": "319.08",
"icms-23-alc": "323.23",
"withoutTaxes": "248.89",
"icms-17.5-alc": "301.68",
"icms-19.5-alc": "309.17",
"icms-20.5-alc": "313.07",
"icms-22.5-alc": "321.14"
},
"invalidBarcodes": [],
"activeSubstances": [
"TEMOZOLOMIDA"
],
"therapeuticClass": "L1A - AGENTES ANTINEOPLÁSICOS ALQUILANTES",
"commercialisation": {
"year": 2025,
"marketed": false
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1029805860014",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "prescription-or-restricted",
"prescriptionRequired": true,
"therapeuticClassCode": "L1A",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:506724060100704"